Nowadays, hepatitis is a major challenge in clinical research, health monitoring authority, and for clinicians. Currently there are more than 100 different types of liver disease, which include alcohol-related liver disease, non-alcoholic fatty liver disease, hepatitis, hemochromatosis and primary biliary cirrhosis. Three of the main causes of liver disease are increase body fat deposition in adipose tissue i.e., obesity, undiagnosed hepatitis infection (Hepatitis B or C virus infections) and alcohol misuse. Very recently conducted a scientific research work on viral load of hepatitis B and C viruses in plasma samples has been published in an International peer-reviewed reputed Journal entitle “Antivirals & Antiretrovirals”. The presence of hepatitis viral particles either DNA or RNA is known as viral load or viral titre. After severe viral infections the viral load can increased in the blood which is one kind of diagnostic bio-marker of hepatitis. It is one of the surrogate biomarker of hepatitis. High viral load indicates that the immune system is failed to fight against viruses. Although several therapeutic aspect are currently available to reduce the viral counts in blood and boost-up the patient immunity and disease severity. However, Mr. Mahendra Kumar Trivedi’s unique biofield energy (The Trivedi Effect®) could able to reduce the level of viral load in hepatitis patient in a very cost-effective manner. Based on studies it was experimentally proven the fruitful impact of The Trivedi Effect® on hepatitis. Overall, the findings indicated that after biofield treatment hepatitis C viral counts were significantly reduced by 67% in plasma sample as compared to control sample. In additionally, the result also showed that viral load of hepatitis B viral counts in infected plasma samples were reduced by 48.39% after biofield treatment as compared to control. The viral particles two viruses those are in multiplying state, possibly affected by Mr. Trivedi’s biofield treatment. Based on the study outcomes give a scientific and fruitful messages to clinician and health regulatory bodies that The Trivedi Effect® could be beneficial to improve the viral load in hepatitis virus infected patients in near future.
